INDUSTRY TRENDS

FDA’s Two Big Moves on NGS-Based Tumor Panels May Offer Clues for Alternative Pathways for LDT Approval

In late November the U.S. Food and Drug Administration (FDA) authorized Memorial Sloan Kettering Cancer Center's Integrated Mutation Profiling of Actionable Cancer Targets tumor profiling test assay … [Read more...]

INDUSTRY TRENDS

Inside the Diagnostics Industry: Laboratory Data Core to Value-Based Health Care

To thrive in the present challenging environment, laboratories need to deliberately focus on how they can create value outside of their own walls. The key to achieving this is in their data. Speakers … [Read more...]

INDUSTRY TRENDS

Diagnostics Industry Responding to Opioid Epidemic

Prescription opioids are among the most common drugs prescribed and are the most effective treating for pain, whether it is debilitating, chronic pain or temporary pain, such as after surgery. While … [Read more...]

INDUSTRY TRENDS

Curetis to Launch Multiplex MDx for Hospital Infections in U.S.

Molecular diagnostics firm Curetis (Germany) specializes in solutions to rapidly diagnose and profile antibiotic resistance for severe infections in hospitalized patients. The company currently has … [Read more...]

NEWS

Testing Guidelines at a Glance

The American Society of Clinical Oncology (ASCO) published updated practice guidelines Aug. 14 in the Journal of Clinical Oncology regarding the use of targeted immunotherapy for patients with stage … [Read more...]

NEWS

Inside the Diagnostics Industry: At-Home Testing Options Expanding

There is a proliferation of companies offering at-home testing. In some cases these are mail-in tests where patients collect their own samples (blood, mouth swab, urine, or stool) and mail them into a … [Read more...]

INDUSTRY TRENDS

Genomic Testing May Be Currently Overhyped, Oncologists Say

Most oncologists believe genomic testing is a major advance, but that it is "significantly overpromoted," according to a survey conducted by Medscape and the Swedish Cancer Institute in … [Read more...]

GENETIC TESTING

Genome Medical Bridges Genomic Testing, Medical Practice

Lisa Alderson, co-founder and CEO, Genome Medical Many well-known barriers are slowing the integration of genomic testing into routine clinical practice, including workforce shortages and a lack … [Read more...]

RESEARCH

iSpecimen Generates New Market for Discarded Biospecimens

iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built a turnkey solution that connects providers, such … [Read more...]

RESEARCH

iSpecimen Creates Marketplace for Clinical Discards

iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built a turnkey solution that connects providers, such … [Read more...]


(-0000g2)